GlassScriptPhysician profile
Racquel D Spencer
NPI 1841589900
$9,924.87
in general payments reported to CMS, 2019-2025
37 companies · $1,246 in 2025
The $1,246 reported for 2025 was more than what 89% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,205 · 2020: $1,373 · 2021: $1,581 · 2022: $1,589 · 2023: $1,323 · 2024: $1,607 · 2025: $1,246.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,177.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,176.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $2,766.16 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $1,723.43 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Lilly USA, LLC | $822.32 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Glaxosmithkline, LLC. | $767.81 | 2019-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Abbott Laboratories | $578.44 | 2021-2025 | Freestyle Libre, Freestyle Libre 3 |
| Abbvie INC. | $542.25 | 2021-2024 | Qulipta, Ubrelvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $416.16 | 2019-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $361.45 | 2019-2022 | |
| Phathom Pharmaceuticals, INC. | $205.24 | 2024-2025 | Voquezna |
| Pfizer INC. | $192.83 | 2019-2025 | |
| Amgen INC. | $154.15 | 2019-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $132.06 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $108.93 | 2019-2021 | |
| Allergan, INC. | $102.13 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $101.29 | 2019-2024 | Xifaxan, Trulance |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Racquel Spencer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.